Treos Bio, a biotech using data science and proprietary biomarkers to develop precision peptide immunotherapies, has presented results from its Phase II OBERTO-301 study. A clinical-stage biotech ...

Generics giant Teva Pharmaceutical Industries and fellow Israel-based artificial intelligence (AI) focused biotech Biolojic Design have signed a license agreement to develop a potential novel antibody ...

While cancer-focused pharma and biotech are busy presenting their latest research achievements at the ongoing American Society of Clinical Oncology (ASCO) meeting, Germany’s Merck KGaA (MRK: DE) ...

Privately-held UK clinical-stage firm Soterios Pharma has announced positive multi-dose Phase II trial evaluating STS-01 as ...

The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, ...

With a steady flow of oncology results emerging from the ongoing ASCO meeting, a company such as Pierre Fabre, which does not have major data to present, might not usually claim the spotlight.

Market and contract research organization IQVIA has published its Global Oncology Trends report for 2024, projecting a ...

Globally, the devastating and widespread impact of neurological disorders like Alzheimer's disease, epilepsy, Parkinson’s ...

The groups will work together to enhance Africa's vaccine infrastructure, with CEPI committing up to $145 million to ...

The US Food and Drug Administration yesterday approved Bristol Myers Squibb’s (NYSE: BMY) Breyanzi (lisocabtagene maraleucel ...

Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase III MDD3001 trial for seltorexant, a selective ...

The Bill & Melinda Gates Medical Research Institute (Gates MRI) has appointed Patrice Matchaba, as chief executive (CEO), ...